Related Experiment Video

Updated: May 23, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Novel candidate genes of thyroid tumourigenesis identified in Trk-T1 transgenic mice

Katrin-Janine Heiliger1, Julia Hess, Donata Vitagliano

  • 1Research Unit of Radiation Cytogenetics, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany.

Endocrine-Related Cancer
|March 29, 2012
PubMed

Insights

This study identifies novel gene copy number alterations in thyroid tumors using a mouse model. These genetic changes, including gains and losses, are also found in human papillary thyroid cancer, offering new insights into tumor development.

Area of Science:

  • Genomics
  • Cancer Biology
  • Molecular Genetics

Background:

  • Thyroid tumourigenesis involves complex genetic alterations.
  • Identifying novel candidate genes is crucial for understanding disease mechanisms.

Purpose of the Study:

  • To identify novel candidate genes involved in thyroid tumourigenesis.
  • To investigate gene copy number changes in a Trk-T1 transgenic mouse model.
  • To correlate findings with human papillary thyroid carcinoma (PTC).

Main Methods:

  • Comparative genomic hybridization (CGH) on 30 mouse thyroid tumors.
  • Gene Ontology (GO) term enrichment analysis.
  • Fluorescence in situ hybridization (FISH) and quantitative reverse transcription PCR (qRT-PCR) on human PTC samples.

Main Results:

  • Recurrent copy number alterations (gains and losses) identified in mouse thyroid tumors.
  • Specific genes (e.g., TWIST2, PTMA, PDE6D, UNC5C, TP73, SLITRK5) showed copy number changes and altered expression in human PTC.
  • Significant gene expression changes observed for UNC5C, TP73, and SLITRK5 in human PTC.

Conclusions:

  • Global genomic copy number analysis reveals novel gene alterations in thyroid tumourigenesis.
  • Identified genetic alterations are prevalent in human papillary thyroid carcinoma.
  • These findings provide potential new targets for understanding and treating thyroid cancer.

More Related Videos

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...